LONZA GROUP AG UNSP ADR EACH RE - stock earnings
LZAGY Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2022Q4 | 361.5 million USD | 1.6 billion USD |
2022Q3 | 361.5 million USD | 1.6 billion USD |
2022Q2 | 246.0 million USD | 1.5 billion USD |
2022Q1 | 246.0 million USD | 1.5 billion USD |
2021Q4 | 1.3 billion CHF | 1.4 billion CHF |
2021Q3 | 1.3 billion CHF | 1.4 billion CHF |
2021Q2 | 159.5 million CHF | 1.3 billion CHF |
2021Q1 | 159.5 million CHF | 1.3 billion CHF |
2019Q4 | 272.5 million USD | 2.3 billion USD |
2019Q3 | 179.1 million USD | 1.5 billion USD |
2019Q2 | 180.1 million USD | 1.8 billion USD |
2019Q1 | 152.4 million USD | 1.5 billion USD |
2018Q2 | 203.3 million USD | 1.6 billion USD |
2018Q1 | 220.6 million USD | 1.7 billion USD |
2017Q4 | 258.5 million USD | 1.5 billion USD |
2017Q3 | 260.6 million USD | 1.5 billion USD |
2017Q2 | 127.3 million USD | 1.3 billion USD |
2017Q1 | 116.1 million USD | 1.2 billion USD |
LZAGY Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2022 | 1.3 billion USD | 6.7 billion USD |
2021 | 3.2 billion USD | 5.9 billion USD |
2020 | 967.4 million USD | 5.0 billion USD |
2019 | 665.7 million USD | 6.1 billion USD |
2018 | 568.3 million USD | 5.6 billion USD |
2017 | 741.9 million USD | 5.2 billion USD |
2016 | 295.7 million USD | 4.1 billion USD |
2015 | 280.4 million USD | 3.8 billion USD |
2014 | 239.8 million USD | 3.7 billion USD |
2013 | 98.1 million USD | 4.0 billion USD |
2012 | 198.9 million USD | 4.3 billion USD |
2011 | 163.8 million USD | 2.9 billion USD |
2010 | 303.9 million USD | 2.9 billion USD |
2009 | 153.8 million USD | 2.6 billion USD |
2008 | 392.3 million USD | 2.7 billion USD |
2007 | 265.8 million USD | 2.5 billion USD |
2006 | 182.1 million USD | 1.9 billion USD |
2005 | 143.0 million USD | 1.9 billion USD |
2004 | 121.4 million USD | 1.9 billion USD |
LZAGY
Price: $57.41
Dividend Yield: 0.07%
Forward Dividend Yield: 0.66%
Payout Ratio: 38.97%
Dividend Per Share: 0.38 USD
Earnings Per Share: 0.97 USD
P/E Ratio: 30.13
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 52072
Ebitda: 1.0 billionMarket Capitalization: 42.4 billion
Average Dividend Frequency: 1
Years Paying Dividends: 15
DGR3: 30.00%
DGR5: 18.13%
DGR10: 30.00%